In early January, we told you that Big Pharma players were starting the New Year with $70 billion in cash on their balance sheets - meaning the "buyout binge" that started in 2012 was certain to carry over into 2013.
And that's just what's happened.
Faced with patent expirations on existing blockbuster drugs, and pipelines that are bereft of replacements, Big Pharma players have been all year long to buy companies outright, to buy product lines or R&D portfolios, or just to purchase individual drugs.
To continue reading, please click here...
This is premium content for Private Briefing subscribers only.
Money Morning's Executive Editor, Bill Patalon, just found a secret backdoor way for you to make a fortune on the Alibaba IPO - before it even goes public... This opportunity will never present itself again... In fact, experts claim the Alibaba IPO date is likely to happen during the first week of September. Once the Alibaba IPO goes live, this special opportunity will cease to exist. Bill's estimating a quick 160% gain in the short run... and much bigger after that. Click here before it's too late.